King s College Hospital NHS Foundation Trust. Acute Liver Disease: what you really need to know.

Size: px
Start display at page:

Download "King s College Hospital NHS Foundation Trust. Acute Liver Disease: what you really need to know."

Transcription

1 King s College Hospital NHS Foundation Trust Acute Liver Disease: what you really need to know. William Bernal Professor of Liver Critical Care Liver Intensive Therapy Unit Institute of Liver Studies Kings College Hospital United Kingdom NHS Update on Acute Medical and Surgical Emergencies for Psychiatrists Royal College of Psychiatrists 21 st May 2018

2 Acute Liver Disease: what you really need to know. Liver Intensive Therapy Unit Institute of Liver Studies Kings College Hospital

3 Acute Liver Disease What you really need to know: Overview. Abnormal Liver Blood tests: What they mean, when to worry & what to do. Hepatic Medical Emergences: Liver Failure Chronic Liver Disease (CLD) Acute Decompensation (AD): what to do? Acute on Chronic Liver failure (ACLF): what is it? Acute Liver Failure (ALF) Recognition and response

4 Liver Blood Tests Panels vary by laboratory: Hepatobiliary Enzymes Alanine / Aspartate Transaminases (ALT/AST) Alkaline Phosphatase (ALP) Gamma Glutamyl Transferase (GGT) Liver Synthetic Function Tests Bilirubin INR (or Prothrombin Time) Albumin Platelet Count

5 Liver Blood Tests Hepatobiliary Enzymes Enzyme Site Normal Range ALP AST/ALT Biliary Epithelium (Bone /Placenta) Hepatocytes (Muscle) GGT Hepatocytes / Biliary tract Reflects Elevation IU/l Biliary disease Cholestasis Obstruction Infiltration IU/l Hepatocyte injury / death 1-55 IU/l Enzyme Induction Cholestasis Hepatitis Hepatic necrosis Congestion Alcohol Steatosis Drugs

6 Liver Blood Tests Liver Synthetic Function Tests Test Normal Range Reflects Bilirubin 3-20 µmol/l Haem metabolism (Haemolysis) Albumin g/l Hepatic synthesis (Loss/Consumption) INR Hepatic Synthesis (Vitamin K Deficiency) Platelets x10 9 /l Splenic sequestration Bone marrow suppression Abnormal Gilberts Syndrome Parenchymal Liver disease Biliary Obstruction Parenchymal Liver disease Parenchymal Liver disease Portal Hypertension Alcohol toxicity

7 Liver Blood Tests Three Common Patterns of Abnormality Pattern Abnormal Tests Causes Clues Isolated Raised Bilirubin Bilirubin Gilberts Syndrome Otherwise Well Haemolysis Anaemia Cholestatic Elevated ALP / GGT Drugs / Alcohol Exposure Obstruction Jaundice Hepatocellular Hepatitic Elevated AST /ALT Liver Cell Injury Hepatic insult

8 Liver Blood Tests Response to abnormal liver blood tests Newsome et al Gut ;0:1-14

9 Liver Blood Tests History Alcohol / Metabolic syndrome & BMI Drug History / Viral risk factors Family history / comorbidity Isolated Raised Bilirubin Otherwise normal LBTs Isolated Cholestatic Liver Enzymes GGT & ALP Hepatitic Liver Enzymes AST / ALT Consider Magnitude Synthetic Failure Jaundice INR Albumin Further Review Concerns: Magnitude Haemolysis Further Review Concerns: Magnitude Absence of obvious cause Weight loss Other abnormal liver tests Urgent Discussion +/ - Urgent Review After Newsome et al Gut ;0:1-14

10 Cholestatic Liver Blood Tests 38 year old Female Psychiatric Inpatient Depression No stigmata CLD. Obese (BMI 35), type 2 DM Teetotal Physically well Long term valproate Rx LBT on admission: Blood tests Albumin 39 Bilirubin 17 ALP 112 AST 45 GGT 289 INR g/l 3-20 µmol/l IU/L IU/L 1-55 IU/L Routine Review Hepatic Steatosis / enzyme induction

11 Hepatitic Liver Blood Tests 46 year old Male Psychiatric Inpatient Depression No stigmata CLD. Obese (BMI 30) Moderate EtOH Treated hypertension, cholesterol Statin, Amlodopine LBT on admission: Blood tests Albumin 40 Bilirubin 14 ALP 110 AST 150 GGT 46 INR g/l 3-20 µmol/l IU/L IU/L 1-55 IU/L Routine Review Statin-related Abnormal LBT

12 Cholestatic Liver Blood Tests 56 year old Male Psychiatric Inpatient Depression No stigmata CLD. Palpable liver edge Thin (BMI 18) Malaise & Weight loss 8 kg. LBT on admission: Blood tests Albumin 29 Bilirubin 60 ALP 450 AST 45 GGT 854 INR g/l 3-20 µmol/l IU/L IU/L 1-55 IU/L Urgent Review Liver infiltrated by adenocarcinoma

13 Acute Liver Disease: Liver Failure Two Distinct Clinical Scenarios Decompensated CLD / ACLF Common Pre-existing liver disease: often Cirrhosis Precipitant and decompensation Hepatic failure +/- encephalopathy Acute Liver Failure (ALF) Rare No pre-existing liver disease Acute hepatic insult: commonly Paracetamol Hepatic failure and encephalopathy Cerebral oedema and intracranial hypertension

14 Chronic Liver Disease

15 Natural History Chronic Liver Disease. Reduced Hepatic Function Jaundice & Coagulopathy Portal Hypertension Ascites and Variceal Bleeding Porto-systemic shunting/ Liver Failure Hepatic Encephalopathy (HE)

16 Natural History Chronic Liver Disease. Stable Compensated Cirrhosis (SC) No ascites or overt Hepatic Encephalopathy (HE) ~ 5-10% patients / year Recompensation of hepatic function Acute Decompensated Cirrhosis (AD) Jaundice, Ascites, HE, Variceal bleeding After Bernal et al Lancet 2015;386:

17 Natural History Chronic Liver Disease. D Amico et al J Hepatology 2006;44:

18 Natural History Chronic Liver Disease Complication 1Year Mortality Variceal Bleeding 20% Ascites 29% Ascites and Variceal Bleeding 49% Hepatic Encephalopathy 64% Jepsen et al Hepatology 2010;51: n=466

19 Natural History Chronic Liver Disease. Stable Compensated Cirrhosis (SC) No ascites or overt HE ~ 5-10% patients / year Recompensation of hepatic function Acute Decompensated Cirrhosis (AD) Jaundice, Ascites, HE, Variceal bleeding ~ 30% hospitalised patients Resolution of organ failures Acute on Chronic Liver Failure (ACLF) Hepatic and Extra-hepatic organ failure? Up to 50% hospitalised patients Death After Bernal et al Lancet 2015;386:

20 Chronic Liver Disease Acute Decompensation Recognise Etiologic clues; Alcohol dependence. Viral Hepatitis. Obesity / diabetes Previously documented Chronic Liver Disease. Previous Decompensation. Physical signs.

21 Chronic Liver Disease: Signs Compensated Stigmata of CLD Spider nevi Loss of body hair Muscle Wasting Gynaecomastia Palmar Erythema Clubbing Leukonychia Testicular atrophy Decompensated Signs of Decompensation Altered mental state Jaundice Hypotension Bruising Ascites Asterixus GI Bleeding Oedema Markers of Severity

22 Cholestatic Liver Blood Tests 44 year old Male Psychiatric Outpatient Heavy alcohol use. BMI 22 Not Jaundiced Palmar Erythema. Spider nevae Palpable liver edge LBT on admission: Blood tests Albumin 36 Bilirubin 30 ALP 98 AST 55 GGT 670 INR g/l 3-20 µmol/l IU/L IU/L 1-55 IU/L Prompt Review Compensated CLD Alcoholic steato-hepatitis

23 54 year old Male Psychiatric Outpatient Heavy alcohol use. Jaundiced Palmar Erythema. Spider nevae Distended abdomen Swollen ankles LBT on admission: Mixed Liver Blood Tests Blood tests Albumin 30 Bilirubin 110 ALP 70 AST 120 GGT 980 INR g/l 3-20 µmol/l IU/L IU/L 1-55 IU/L Immediate Review Decompensated CLD Alcoholic Hepatitis

24 Chronic Liver Disease Precipitants of Acute Decompensation Alcohol-related hepatitis Sepsis Sepsis Drugs (NSAIDs, Opiates, Benzos) Gastro-intestinal bleeding Ischaemic liver injury (sepsis or hypotension) Acute portal vein thrombosis Development of hepatocellular carcinoma

25 Chronic Liver Disease Acute Decompensation Actions Seek help and prompt bedside review or transfer. Impaired Consciousness / Cardiovascular instability: urgent. Seek / Remove precipitant and initiate Rx. Medication: minimise or discontinue. Benzoidepines / Zopiclone / Opiates Non-steroidals Volume depletion / Electrolyte anomalies: Rehydrate and correct. Renal dysfunction Hyponatraemia Seek / treat sepsis: empiric Rx if concerned. Don t delay

26 Chronic Liver Disease Early Ward Intervention Cirrhosis and Outcome of Septic Shock: Antibiotic Delay Arabi et al Hepatology 2012 ;56: Adjusted OR ; APACHE II, MELD, Immune compromise, Culture +ve

27 Chronic Liver Disease: AD/ACLF Escalation of care? NCEPOD 2013 Alcohol Related Liver Disease: Measuring the Units Both Advisors and clinicians identified patients in whom escalation of care was not received despite it being indicated....escalation of care should be actively pursued for patients with Alcohol-related Liver disease who deteriorate acutely and whose background functional status is good. There should be close liaison between the medical and critical care teams when making escalation decisions..

28 ALF the basics: Epidemiology Rare. Younger Adults. High Mortality. Location Era Age Gender Mortality Incidence Spain % F 41% 1.4 / million / year Georgia, USA % F 47% 5.5 / million / year Scotland % F 29% 6.2 / million / year 1 Escorsell et al Liver Transplantation : Bower et al Am J Gastroenterology 2007;102: Bretherick et al QJM 2011; 104:

29 ALF the basics: Causes. Aetiology of ALF/ALI Kings College Hospital n=1204 Paracetamol Non-Paracetamol Bernal et al Unpublished 2018

30 ALF the basics: Causes. Aetiology of Non-Paracetamol ALF/ALI Kings College Hospital n=539 Indeterminate DILI Pregnancy-related Viral Ischemia/Hypoxia Malignancy Auto Immune Budd Chiari Wilsons Other Bernal et al Unpublished 2018

31 ALF: Initial Management Recognise early Circumstantial clues Unexplained confusion / hypoglycaemia Elevated transaminases / coagulopathy Resuscitate Give N-acetyl cysteine (NAC) Give Antibiotics Discuss

32 ALF: Recognise Early High Risk Paracetamol: Nature & Circumstances of OD Delayed diagnosis Unexplained Agitation / Drowsiness Delayed / Discontinued N-acetyl Cysteine Enhanced hepatotoxicity Coexistent CLD Anorexia / Low BMI HIV

33 ALF: Recognise Early High Risk Paracetamol Cases Staggered Consumption Delayed Presentation n=611 p<0.01 n=396 p< Craig et al Br J Clin Pharmacol :2:

34 ALF: Recognise Early Delayed / Discontinued / Unused N-acetyl Cysteine..A paracetamol concentration either above or just below the line at any time beyond 15 hours of non-staggered ingestion is an indication for treatment with NAC. Postgrad Med J 2005;81:

35 ALF: N-acetyl Cysteine (NAC) When to administer? Use the nomogram only as a guide. <8 hrs after ingestion & non-staggered OD Check [paracetamol] and treat if required 8-15 hours Toxic ingestion: start NAC, check [paracetamol] >15 hours after ingestion and non-staggered OD Toxic ingestion: start NAC, check [paracetamol] Staggered OD >150 mg/kg (>75 if high risk) in 24 hrs give NAC If in doubt give NAC and discuss.

36 ALF: Recognise Early 23 year old Female Psychiatric Inpatient 1 week Depression / DSH No stigmata CLD. Normal LBT on admission Absconded Friday Agitated late Sunday night Hypoglycaemic Blood tests Albumin 36 Bilirubin 38 ALP 112 AST 5476 GGT 25 INR g/l 3-20 µmol/l IU/L IU/L 1-55 IU/L Immediate Transfer & NAC ALF: Paracetamol

37 ALF: Recognise Early 28 year old Male Psychiatric Inpatient High risk sexual practices Hospitalised under section 1 month. No stigmata CLD. Normal LBT on admission 12 hours lethargy, withdrawn Hypoglycaemic Blood tests Albumin 30 Bilirubin 180 ALP 96 AST 1876 GGT 150 INR g/l 3-20 µmol/l IU/L IU/L 1-55 IU/L Immediate Transfer ALF: Acute Hepatitis B

38 Hospital Survival (%) 90% ALF: Ongoing management. Changing Outcomes Hospital survival in patients with Acute Liver Disease. King s College Hospital n= % 70% 60% 50% 40% 30% 20% 10% 0% p< Bernal Journal of Hepatology. 59 (1):74-80, 2013

39 Acute Liver Disease: what you really need to know. Identification: History / Examination / Liver Blood Tests. Alarm: Systemic symptoms & Signs / Synthetic dysfunction. Chronic Liver Disease >> Acute Liver Failure Chronic Liver Disease Signs / Laboratory tests of decompensation. Urgent transfer / fluids / antibiotics. Acute Liver Failure Early recognition. Liver Blood tests: Hepatic Necrosis / Synthetic Failure. Most commonly Paracetmol: NAC and urgent transfer.

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry MPharm Programme Liver Biochemistry Slide 1 of 49 MPHM Liver Biochemistry Learning Outcomes Assess and evaluate the signs and symptoms of illness Assess and critically appraise a patients medication regimen,

More information

King s College Hospital NHS Foundation Trust. Acute on Chronic Liver Failure: Practical management outside the tertiary centre.

King s College Hospital NHS Foundation Trust. Acute on Chronic Liver Failure: Practical management outside the tertiary centre. King s College Hospital NHS Foundation Trust NHS Acute on Chronic Liver Failure: Practical management outside the tertiary centre. William Bernal Professor of Liver Critical Care Liver Intensive Therapy

More information

A Review of Liver Function Tests. James Gray Gastroenterology Vancouver

A Review of Liver Function Tests. James Gray Gastroenterology Vancouver A Review of Liver Function Tests James Gray Gastroenterology Vancouver Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted

More information

ABNORMAL LIVER FUNCTION TESTS. Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust

ABNORMAL LIVER FUNCTION TESTS. Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust ABNORMAL LIVER FUNCTION TESTS Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust INTRODUCTION Liver function tests Cases Non invasive fibrosis measurement Questions UK MORTALITY RATE

More information

CHAPTER 1. Alcoholic Liver Disease

CHAPTER 1. Alcoholic Liver Disease CHAPTER 1 Alcoholic Liver Disease Major Lesions of Alcoholic Liver Disease Alcoholic fatty liver - >90% of binge and chronic drinkers Alcoholic hepatitis precursor of cirrhosis Alcoholic cirrhosis end

More information

EVALUATION OF ABNORMAL LIVER TESTS

EVALUATION OF ABNORMAL LIVER TESTS EVALUATION OF ABNORMAL LIVER TESTS MIA MANABAT DO PGY6 MOA 119 TH ANNUAL SPRING SCIENTIFIC CONVENTION MAY 19, 2018 EVALUATION OF ABNORMAL LIVER TESTS Review of liver enzymes vs liver function tests Clinical

More information

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association CIRRHOSIS AND PORTAL HYPERTENSION Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association WHAT IS CIRRHOSIS? What is Cirrhosis? DEFINITION OF CIRRHOSIS

More information

Drug Induced Liver Injury (DILI)

Drug Induced Liver Injury (DILI) Drug Induced Liver Injury (DILI) Aisling Considine- Consultant Hepatology Pharmacist. King s College Hospital NHS Foundation Trust aislingconsidine@nhs.net Drug Induced Liver Injury /Disease Acute Liver

More information

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow R.J.Bailey MD Hepatocytes produce Proteins Clotting factors Hormones Bile Flow Trouble.. for the liver! Trouble for the Liver Liver Gall Bladder Common Alcohol Hep C Fatty Liver Cancer Drugs Viruses Uncommon

More information

What to do with abnormal LFTs? Andrew M Smith Hepatobiliary Surgeon

What to do with abnormal LFTs? Andrew M Smith Hepatobiliary Surgeon What to do with abnormal LFTs? Andrew M Smith Hepatobiliary Surgeon "it looks like there's something wrong.with your television set. Matt Groenig, creator of The Simpsons Probability of an abnormal screening

More information

Abnormal Liver Chemistries. Lauren Myers, MMsc. PA-C Oregon Health and Science University

Abnormal Liver Chemistries. Lauren Myers, MMsc. PA-C Oregon Health and Science University Abnormal Liver Chemistries Lauren Myers, MMsc. PA-C Oregon Health and Science University Disclosure 1. The speaker/planner Lauren Myers, MMSc, PA-C have no relevant financial relationships to disclose

More information

Mrs Janet Catt. Pre-Conference Nurse s Course. Royal Free London NHS Foundation Trust. Janet Catt MSc RN Lead Nurse Specialist Practic 12/12/2014

Mrs Janet Catt. Pre-Conference Nurse s Course. Royal Free London NHS Foundation Trust. Janet Catt MSc RN Lead Nurse Specialist Practic 12/12/2014 Pre-Conference Nurse s Course in partnership with Mrs Janet Catt Royal Free London NHS Foundation Trust Janet Catt MSc RN Lead Nurse Specialist Practic 1 Liver blood tests monitoring cirrhosis HIV/HCV

More information

Interpreting Liver Function Tests

Interpreting Liver Function Tests PSH Clinical Guidelines Statement 2017 Interpreting Liver Function Tests Dr. Asad A Chaudhry Consultant Hepatologist, Chaudhry Hospital, Gujranwala, Pakistan. Liver function tests (LFTs) generally refer

More information

Patterns of abnormal LFTs and their differential diagnosis

Patterns of abnormal LFTs and their differential diagnosis Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Outline liver function tests / tests of

More information

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

2. Liver blood tests and what they mean p2 Acute and chronic liver screen Hepatology referral pathways for GP 1 Scope For use within hepatology Contents 2. Liver blood tests and what they mean p2 Acute and chronic liver screen p2 Common reasons for hepatology referral 3. Raised

More information

Liver failure &portal hypertension

Liver failure &portal hypertension Liver failure &portal hypertension Objectives: by the end of this lecture each student should be able to : Diagnose liver failure (acute or chronic) List the causes of acute liver failure Diagnose and

More information

Approach to the Patient with Liver Disease

Approach to the Patient with Liver Disease Approach to the Patient with Liver Disease Diagnosis of liver disease Careful history taking Physical examination Laboratory tests Radiologic examination and imaging studies Liver biopsy Liver diseases

More information

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob: Diseases of liver Dr. Mohamed. A. Mahdi Mob: 0123002800 4/2/2019 Cirrhosis Cirrhosis is a complication of many liver disease. Permanent scarring of the liver. A late-stage liver disease. The inflammation

More information

Acute Liver Failure. Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018

Acute Liver Failure. Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018 Acute Liver Failure Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018 Disclosures None Outline Overview of ALF Management of ALF Diagnosis of ALF Treatments and Support

More information

I have no disclosures relevant to this presentation LIVER TESTS: WHAT IS INCLUDED? LIVER TESTS: HOW TO UTILIZE THEM OBJECTIVES

I have no disclosures relevant to this presentation LIVER TESTS: WHAT IS INCLUDED? LIVER TESTS: HOW TO UTILIZE THEM OBJECTIVES LIVER TESTS: HOW TO UTILIZE THEM I have no disclosures relevant to this presentation José Franco, MD Professor of Medicine, Surgery and Pediatrics Medical College of Wisconsin OBJECTIVES Differentiate

More information

Chapter 143 Acetaminophen

Chapter 143 Acetaminophen Chapter 143 Acetaminophen Episode overview 1) Describe the metabolism of Acetaminophen 2) Describe the 4 stages of Acetaminophen toxicity 3) List 4 mechanism of action of N-acetylcysteine 4) When do you

More information

PACT module Acute hepatic failure. Intensive Care Training Program Radboud University Medical Centre Nijmegen

PACT module Acute hepatic failure. Intensive Care Training Program Radboud University Medical Centre Nijmegen PACT module Acute hepatic failure Intensive Care Training Program Radboud University Medical Centre Nijmegen Acute Liver Failure Acute on Chronic Liver Failure Acute loss of hepatocellular function in

More information

CITY AND HACKNEY CCG ABNORMAL LIVER FUNCTION TESTS (LFTs) in ADULTS

CITY AND HACKNEY CCG ABNORMAL LIVER FUNCTION TESTS (LFTs) in ADULTS CITY AND HACKNEY CCG ABNORMAL LIVER FUNCTION TESTS (LFTs) in ADULTS Interpreting abnormal liver function tests (LFTs) and trying to diagnose any underlying liver disease is a common scenario in Primary

More information

Patterns of abnormal LFTs and their differential diagnosis

Patterns of abnormal LFTs and their differential diagnosis Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Outline liver function / liver function

More information

Mr Ricky Gellissen Imperial College Healthcare NHS Trust, London, UK

Mr Ricky Gellissen Imperial College Healthcare NHS Trust, London, UK Mr Ricky Gellissen Imperial College Healthcare NHS Trust, London, UK Ms Sally Bufton University Hospital Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham Mrs Janet Catt Royal Free

More information

Infective Liver Disease

Infective Liver Disease The Role oeofdrugs in Non Infective Liver Disease Peter Tenni Senior Lecturer in Therapeutics, School of Pharmacy University of Tasmania Senior Research Fellow Unit for Medication Outcomes Research and

More information

PACT module Acute hepatic failure. Intensive Care Training Program Radboud University Medical Centre Nijmegen

PACT module Acute hepatic failure. Intensive Care Training Program Radboud University Medical Centre Nijmegen PACT module Acute hepatic failure Intensive Care Training Program Radboud University Medical Centre Nijmegen Acute Liver Failure Acute on Chronic Liver Failure Acute loss of hepatocellular function in

More information

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

2. Liver blood tests and what they mean p2 Acute and chronic liver screen 1 Scope For use within hepatology Contents 2. Liver blood tests and what they mean p2 Acute and chronic liver screen p2 Common reasons for referral 3. Raised ALT +/- GGT p3 4. Non alcoholic fatty liver

More information

Alcoholic Hepatitis: Routine Screening for Early Recognition and Management. Juan Guerrero, MD

Alcoholic Hepatitis: Routine Screening for Early Recognition and Management. Juan Guerrero, MD Alcoholic Hepatitis: Routine Screening for Early Recognition and Management Juan Guerrero, MD Global Problem 1% of GNP of medium/high income countries Additional societal costs Disproportionately affects

More information

CrackCast Episode 28 Jaundice

CrackCast Episode 28 Jaundice CrackCast Episode 28 Jaundice Episode overview: 1) Describe heme metabolism 2) List common pre-hepatic/hepatic/post-hepatic causes of jaundice Wisecracks: 1) What are clinical signs of liver disease? 2)

More information

CONTROLLED DOCUMENT. Cirrhosis Care Bundle CATEGORY: Clinical Guidelines. CLASSIFICATION: Clinical. Controlled Document CG201 Number:

CONTROLLED DOCUMENT. Cirrhosis Care Bundle CATEGORY: Clinical Guidelines. CLASSIFICATION: Clinical. Controlled Document CG201 Number: Cirrhosis Care Bundle CONTROLLED DOCUMENT CATEGORY: Clinical Guidelines CLASSIFICATION: Clinical Controlled Document CG201 Number: Version Number: 1 Controlled Document Clinical Guidelines Group Sponsor:

More information

MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT

MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT Sherona Bau, ACNP The Pfleger Liver Institute 200 UCLA Medical Plaza, Suite 214 Los Angeles, CA 90095 September 30, 2017 I

More information

LIVER DISORDERS (PRACTICAL MANAGEMENT) Dr Pok Kern (PK) TAN Gastroenterologist Calvary hospital, ACT 1 st April 2017

LIVER DISORDERS (PRACTICAL MANAGEMENT) Dr Pok Kern (PK) TAN Gastroenterologist Calvary hospital, ACT 1 st April 2017 LIVER DISORDERS (PRACTICAL MANAGEMENT) Dr Pok Kern (PK) TAN Gastroenterologist Calvary hospital, ACT 1 st April 2017 TOPICS TO COVER Acute liver failure Chronic liver failure Portal hypertension : Ascites

More information

Biochemical Investigations in Liver Disease. Dr Roshitha de Silva Department of Pathology Faculty of Medicine University of Kelaniya

Biochemical Investigations in Liver Disease. Dr Roshitha de Silva Department of Pathology Faculty of Medicine University of Kelaniya Biochemical Investigations in Liver Disease Dr Roshitha de Silva Department of Pathology Faculty of Medicine University of Kelaniya Biochemical markers Albumin ALP ALT, AST Gamma-glutamyl transpeptidase

More information

LIVER FUNCTION TESTS. G M Kellerman. Hunter Area Pathology Service

LIVER FUNCTION TESTS. G M Kellerman. Hunter Area Pathology Service LIVER FUNCTION TESTS G M Kellerman Hunter Area Pathology Service FUNCTIONS OF LIVER Carbohydrate metabolism storage (glycogen), release, synthesis (gluconeogenesis), interconversion (galactose, fructose),

More information

Jaundice. Agnieszka Dobrowolska- Zachwieja, MD, PhD

Jaundice. Agnieszka Dobrowolska- Zachwieja, MD, PhD Jaundice Agnieszka Dobrowolska- Zachwieja, MD, PhD Jaundice definition Jaundice, as in the French jaune, refers to the yellow discoloration of the skin. It arises from the abnormal accumulation of bilirubin

More information

World Health Organization. Western Pacific Region

World Health Organization. Western Pacific Region Basic modules for hepatitis 1 Basic Module 1 Liver anatomy and physiology 2 Position of liver Midline Located in right upper abdomen Protected by the right rib cage Right upper Measures: 12 15 cm in vertical

More information

The Yellow Patient. Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust

The Yellow Patient. Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust The Yellow Patient Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust there s a yellow patient in bed 40. It s one of yours. Liver Cirrhosis Why.When.What.etc.

More information

HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management

HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management Stephen G. M. Wong BSc, BSc(Med), MD, MHSc, FRCPC Associate Professor of Medicine Director, Hepatology Education Section of Hepatology

More information

Initial Evaluation for HCV Therapy. Hope McGratty PA-C, MPH

Initial Evaluation for HCV Therapy. Hope McGratty PA-C, MPH Initial Evaluation for HCV Therapy Hope McGratty PA-C, MPH Conflict of Interest Disclosure Statement None Who are we talking about today? Treatment naïve Chronic infection This patient seems complicated

More information

Liver Failure. The most severe clinical consequence of liver disease is liver failure:

Liver Failure. The most severe clinical consequence of liver disease is liver failure: Liver diseases I The major primary diseases of the liver are: - Viral hepatitis, - Nonalcoholic fatty liver disease (NAFLD), - Alcoholic liver disease, - Hepatocellular carcinoma (HCC) Hepatic damage also

More information

Drug therapy in patient with hepatic impairment

Drug therapy in patient with hepatic impairment Drug therapy in patient with hepatic impairment Arzneimitteltherapie bei Leberinsuffizienz Dominik Wilke 03/04 Mai 2018 43. ADKA-Kongress, Stuttgart Functions of the Liver I Metabolism (Carbohydrates,

More information

Etiology of liver cirrhosis

Etiology of liver cirrhosis Liver cirrhosis 1 Liver cirrhosis Liver cirrhosis is the progressive replacement of normal hepatic cells by fibrous scar tissue, This scarring is accompanied by the loss of viable hepatocytes, which are

More information

Hepatology for the Nonhepatologist

Hepatology for the Nonhepatologist Hepatology for the Nonhepatologist Kenneth E. Sherman, MD, PhD Gould Professor of Medicine Director, Division of Digestive Diseases University of Cincinnati College of Medicine Cincinnati, Ohio Learning

More information

Podcast (Video Recorded Lecture Series): Portal HTN and Derivatives for the USMLE Step One Exam. Ultrasound (w/ doppler) Reversal of flow Portal Vein

Podcast (Video Recorded Lecture Series): Portal HTN and Derivatives for the USMLE Step One Exam. Ultrasound (w/ doppler) Reversal of flow Portal Vein Podcast (Video Recorded Lecture Series): Portal HTN and Derivatives for the USMLE Step One Exam Hepatic Vein (Budd Chiari) Ultrasound (w/ doppler) Reversal of flow Portal Vein Howard J. Sachs, MD www.12daysinmarch.com

More information

HOW TO DEAL WITH THOSE ABNORMAL LIVER ENZYMES David C. Twedt DVM, DACVIM Colorado State University Fort Collins, CO

HOW TO DEAL WITH THOSE ABNORMAL LIVER ENZYMES David C. Twedt DVM, DACVIM Colorado State University Fort Collins, CO HOW TO DEAL WITH THOSE ABNORMAL LIVER ENZYMES David C. Twedt DVM, DACVIM Colorado State University Fort Collins, CO The identification of abnormal liver enzymes usually indicates liver damage but rarely

More information

Liver disease in 2017: challenges and opportunities

Liver disease in 2017: challenges and opportunities Liver disease in 2017: challenges and opportunities Dr Matthew Cowan Consultant Gastroenterologist and Hepatologist Surrey and Sussex Healthcare NHS Trust Faculty of Physician Associates 2 nd National

More information

Current Concepts in Diagnosis and Management of Acute Liver Failure

Current Concepts in Diagnosis and Management of Acute Liver Failure Current Concepts in Diagnosis and Management of Acute Liver Failure Oren Fix, MD, MSc, FACP, AGAF, FAASLD Medical Director, Liver Transplant Program Swedish Medical Center Seattle, WA Learning Objectives

More information

MANAGEMENT OF ACUTE HEPATIC FAILURE

MANAGEMENT OF ACUTE HEPATIC FAILURE MANAGEMENT OF ACUTE HEPATIC FAILURE -NEW CONCEPT PROF. DR.MD ZAKIR HOSSAIN PROFESSOR & HEAD DEPARTMENT OF MEDICINE RANGPUR MEDICAL COLLEGE & HOSPITAL Rangpur Medical College & Hospital Begum Rokeya Shakhawat

More information

Investigations before OLT, Immunosuppression and rejection, Follow up after OLT.

Investigations before OLT, Immunosuppression and rejection, Follow up after OLT. Investigations before OLT, Immunosuppression and rejection, Follow up after OLT andrea.degottardi@insel.ch When is liver transplantation indicated? When is liver transplantation indicated? Frequent: CIRRHOSIS

More information

Autoimmune Hepatitis: Defining the need for Liver Transplantation

Autoimmune Hepatitis: Defining the need for Liver Transplantation Autoimmune Hepatitis: Defining the need for Liver Transplantation Michael A Heneghan, MD, MMedSc, FRCPI. Institute of Liver Studies, King s College Hospital, London Outline Autoimmune Hepatitis Background

More information

VIRAL HEPATITIS. Definitions. Acute Liver Disease (Hepatitis A &E, Alcoholic hepatitis, DILI and ALF) Acute Viral Hepatitis Symptoms

VIRAL HEPATITIS. Definitions. Acute Liver Disease (Hepatitis A &E, Alcoholic hepatitis, DILI and ALF) Acute Viral Hepatitis Symptoms Acute Liver Disease (Hepatitis A &E, Alcoholic hepatitis, DILI and ALF) Definitions AST and ALT Markers of hepatocellular injury Ryan M. Ford, MD Assistant Professor of Medicine Director of Viral Hepatitis

More information

Acute liver failure. Authors: Laura Blackmore A and William Bernal B ABSTRACT. Aetiology. Introduction. Presentation

Acute liver failure. Authors: Laura Blackmore A and William Bernal B ABSTRACT. Aetiology. Introduction. Presentation CME EMERGENCIES IN GASTROENTEROLOGY Clinical Medicine 5 Vol 5, No 5: 6 7 Acute liver failure Authors: Laura Blackmore A and William Bernal B ABSTRACT Acute liver failure (ALF) is a rare critical illness

More information

Module 1 Introduction of hepatitis

Module 1 Introduction of hepatitis Module 1 Introduction of hepatitis 1 Training Objectives At the end of the module, trainees will be able to ; Demonstrate improved knowledge of the global epidemiology of the viral hepatitis Understand

More information

Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland

Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland Sanjiv Chopra, MD, MACP Professor of Medicine Harvard Medical School Editor In Chief Hepatology Section Up To Date Serum

More information

Contraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for:

Contraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for: Contraindications Absolute Relative Primary prevention variceal bleeding HCC if centrally located Active congestive heart failure Obstruction all hepatic veins Thomas D. Boyer, M.D. University of Arizona

More information

Biochemistry Liver Function Tests (LFTs)

Biochemistry Liver Function Tests (LFTs) HbA NH 2 H 2 O 2 KClO3 Cl 2 O 7 PO 4 CH2O NAOH KMnO 4 M E D I C I N E KING SAUD UNIVERSITY Co 2 COOH MgCl 2 H 2 O Important Extra Information Doctors slides Doctors notes SO 2 HCN CCl 4 CuCl 2 SiCl 4 Biochemistry

More information

Approach to Abnormal Liver Tests

Approach to Abnormal Liver Tests Approach to Abnormal Liver Tests Scott W. Biggins, MD, MAS Assistant Professor Division of Gastroenterology UCSF Scott.Biggins@ucsf.edu (Thanks to Hal Yee, MD) This Morning s Presentation Clinical vignettes

More information

THAI J GASTROENTEROL 2014 Vol. 15 No May - Aug. 2014

THAI J GASTROENTEROL 2014 Vol. 15 No May - Aug. 2014 Case Report Poovorawan K, et al. 105 Fatal Acute-on-Chronic Liver Failure from Amiodarone Toxicity Poovorawan K 1,2 Wisedopas N 3 Treeprasertsuk S 1 Komolmit P 1 ABSTRACT Background: Drug induced liver

More information

Acute Liver Failure. Agenda. Natalie H Bzowej, MD, PhD, FRCPC. Case Introduction Definition Diagnosis Initial Laboratory Evaluation Acetaminophen NAC

Acute Liver Failure. Agenda. Natalie H Bzowej, MD, PhD, FRCPC. Case Introduction Definition Diagnosis Initial Laboratory Evaluation Acetaminophen NAC Acute Liver Failure Natalie H Bzowej, MD, PhD, FRCPC Agenda Case Introduction Definition Diagnosis Initial Laboratory Evaluation Acetaminophen NAC 1 Case 27 year old female presents to ER with N/V Denies

More information

Key Aspects of Diagnosing Alcoholic Hepatitis. Mark Sonderup University of Cape Town & Groote Schuur Hospital

Key Aspects of Diagnosing Alcoholic Hepatitis. Mark Sonderup University of Cape Town & Groote Schuur Hospital Key Aspects of Diagnosing Alcoholic Hepatitis Mark Sonderup University of Cape Town & Groote Schuur Hospital 42 year old woman, married with 3 children No significant co-morbidities or illnesses Habits

More information

Good afternoon. Thanks, John, very much for the invitation to be here today. I am delighted to discuss elevated transaminases in the setting of heart

Good afternoon. Thanks, John, very much for the invitation to be here today. I am delighted to discuss elevated transaminases in the setting of heart Good afternoon. Thanks, John, very much for the invitation to be here today. I am delighted to discuss elevated transaminases in the setting of heart failure. 1 I have nothing to disclose, and the opinions

More information

Management of autoimmune hepatitis. Pierre-Emmanuel RAUTOU Inserm U970, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France

Management of autoimmune hepatitis. Pierre-Emmanuel RAUTOU Inserm U970, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France Management of autoimmune hepatitis Pierre-Emmanuel RAUTOU Inserm U970, PARCC@HEGP, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France 41 year-old woman, coming to emergency department for fatigue

More information

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries Paul Y. Kwo, MD, FACG, FAASLD 1, Stanley M. Cohen, MD, FACG, FAASLD 2, and Joseph K. Lim, MD, FACG, FAASLD 3 1 Division of Gastroenterology/Hepatology,

More information

ANAESTHESIA AND LIVER DISEASE: UNDERSTANDING BLOOD RESULTS

ANAESTHESIA AND LIVER DISEASE: UNDERSTANDING BLOOD RESULTS Vet Times The website for the veterinary profession https://www.vettimes.co.uk ANAESTHESIA AND LIVER DISEASE: UNDERSTANDING BLOOD RESULTS Author : Marieke De Vries Categories : Vets Date : September 26,

More information

-Liver function tests -

-Liver function tests - -Liver function tests - Biochimestry teamwork Osamah Al-Jarallah Abdulaziz Al-Shamlan Abdullah Al-Mazyad Turki Al-Otaibi Khalid Al-Khamis Saud Al-awad KhaledAlmohaimede Meshal Al-Otaibi Al-Anood Asiri

More information

Interpreting Liver Tests What Do They Mean? Roman E. Perri, MD

Interpreting Liver Tests What Do They Mean? Roman E. Perri, MD Interpreting Liver Tests What Do They Mean? Roman E. Perri, MD The assessment of patients with abnormal liver tests is common in both primary care and gastroenterology clinics. However, among patients

More information

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries Ashwani K. Singal, MD, MS, FACG 1, Ramon Bataller, MD, PhD, FACG 2, Joseph Ahn, MD, MS, FACG (GRADE Methodologist) 3, Patrick S. Kamath,

More information

Definition: fibrosis and nodular regeneration resulting from hepatocellular injury

Definition: fibrosis and nodular regeneration resulting from hepatocellular injury Cirrhosis Understanding the liver: Patterns of LFT Abnormalities - Hepatocellular/Transaminitis: o Ratio of AST: ALT >2:1 ETOH (keep in mind AST is also produced by red cells, heart muscle) o If Aminotransferases

More information

Disclosure. Evaluation of Abnormal Hepatic Enzymes

Disclosure. Evaluation of Abnormal Hepatic Enzymes Evaluation of Abnormal Hepatic Enzymes Bruce D. Askey, MS, ANP-BC Associate Lecturer North Andover, MA Adult Nurse Practitioner Dept. of Hepatology/Gastroenterology Guthrie Clinic Sayre, Pa Disclosure

More information

Investigating and Referring Incidental Findings of Abnormal Liver Tests

Investigating and Referring Incidental Findings of Abnormal Liver Tests Investigating and Referring Incidental Findings of Abnormal Liver Tests Note on Referral Guidelines: these revised guidelines are presented as a tool to aid appropriate referral and management of common

More information

Complications of Cirrhosis

Complications of Cirrhosis Complications of Cirrhosis Causes of Cirrhosis Alcohol Chronic Viral Hepatitis (B/C) Haemochromatosis Autoimmune Hepatitis NAFLD/NASH Primary Biliary Cirrhosis Primary Sclerosing Cholangitis 1-AT deficiency

More information

DISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea

DISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea DISCLOSURES This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea Cardea Services is approved as a provider of continuing nursing education by Montana Nurses Association,

More information

JAUNDICE. Zdeněk Fryšák 3rd Clinic of Internal Medicine Nephrology-Rheumatology-Endocrinology Faculty Hospital Olomouc

JAUNDICE. Zdeněk Fryšák 3rd Clinic of Internal Medicine Nephrology-Rheumatology-Endocrinology Faculty Hospital Olomouc JAUNDICE Zdeněk Fryšák 3rd Clinic of Internal Medicine Nephrology-Rheumatology-Endocrinology Faculty Hospital Olomouc Definition of Jaundice Icterus A yellowish staining of the skin, sclerae and deeper

More information

Management of Cirrhosis Related Complications

Management of Cirrhosis Related Complications Management of Cirrhosis Related Complications Ke-Qin Hu, MD, FAASLD Professor of Clinical Medicine Director of Hepatology University of California, Irvine Disclosure I have no disclosure related to this

More information

LFTs: an update A MacGilchrist PLIG meeting 31st January 2019

LFTs: an update A MacGilchrist PLIG meeting 31st January 2019 LFTs: an update A MacGilchrist PLIG meeting 31 st January 2019 LFTs: what are we trying to achieve? (1) The case against investigation abnormal LFTs in up to 21% of the population only 1-2% develop significant

More information

EDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem

EDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:1187 1191 EDUCATION PRACTICE Management of Refractory Ascites ANDRÉS CÁRDENAS and PERE GINÈS Liver Unit, Institute of Digestive Diseases, Hospital Clínic,

More information

MANAGEMENT OF DILI in TB/HIV coinfected patients. Chimoio 31 August 2017 by Dr Ndiviwe Mphothulo

MANAGEMENT OF DILI in TB/HIV coinfected patients. Chimoio 31 August 2017 by Dr Ndiviwe Mphothulo MANAGEMENT OF DILI in TB/HIV coinfected patients Chimoio 31 August 2017 by Dr Ndiviwe Mphothulo ANTI-TB drugs Groups Drugs Group 1: First-line oral drugs Ethambutol (Emb) Pyrazinamide(PZA) Isoniazid (INH)

More information

Jaundice Chris Wells Regional CMT teaching 6 th June 2017

Jaundice Chris Wells Regional CMT teaching 6 th June 2017 Jaundice Chris Wells Regional CMT teaching 6 th June 2017 By the end you will Have a systematic approach to the patient with jaundice Be able to diagnose the cause of jaundice Have a framework for managing

More information

Ontario s Adult Referral and Listing Criteria for Liver Transplantation

Ontario s Adult Referral and Listing Criteria for Liver Transplantation Ontario s Adult Referral and Listing Criteria for Liver Transplantation Version 3.0 Trillium Gift of Life Network Ontario s Adult Referral & Listing Criteria for Liver Transplantation PATIENT REFERRAL

More information

CIRROSI E IPERTENSIONE PORTALE NELLA DONNA

CIRROSI E IPERTENSIONE PORTALE NELLA DONNA Cagliari, 16 settembre 2017 CIRROSI E IPERTENSIONE PORTALE NELLA DONNA Vincenza Calvaruso, MD, PhD Ricercatore di Gastroenterologia Gastroenterologia & Epatologia, Di.Bi.M.I.S. Università degli Studi di

More information

Alpha-1 Liver Disease

Alpha-1 Liver Disease Alpha-1 Liver Disease Jeffrey Teckman, M.D. Professor of Pediatrics and Biochemistry Associate Chair of Pediatrics for Research Director, Pediatric Gastroenterology and Hepatology St. Louis University

More information

Suspected Isoflurane Induced Hepatitis from Cross Sensitivity in a Post Transplant for Fulminant Hepatitis from Halothane.

Suspected Isoflurane Induced Hepatitis from Cross Sensitivity in a Post Transplant for Fulminant Hepatitis from Halothane. ISPUB.COM The Internet Journal of Anesthesiology Volume 25 Number 1 Suspected Isoflurane Induced Hepatitis from Cross Sensitivity in a Post Transplant for Fulminant Hepatitis from Halothane. V Sampathi,

More information

GI bleeding in chronic liver disease

GI bleeding in chronic liver disease GI bleeding in chronic liver disease Stuart McPherson Consultant Hepatologist Liver Unit, Freeman Hospital, Newcastle upon Tyne and Institute of Cellular Medicine, Newcastle University. Case 54 year old

More information

NCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease

NCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease NCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease Hospital Number Admission to hospital 5. Trusts should ensure that medical patients are reviewed by a consultant

More information

TB Case Management Hepatitis

TB Case Management Hepatitis TB Case Management Hepatitis Chris Keh, MD TB Controller, TB Prevention and Control Program, San Francisco Department of Public Health Assistant Clinical Professor, Division of Infectious Diseases, University

More information

Noncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids. Cholestasis

Noncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids. Cholestasis Noncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids Cholestasis Biochemical hallmark Impaired bile flow from liver to small intestine Alkaline phosphatase is primary

More information

Management of Hepatitis C in Primary Care BABAFEMI ONABANJO, MD & BEN ALFRED, FNP UMASS FAMILY HEALTH CENTER WORCESTER

Management of Hepatitis C in Primary Care BABAFEMI ONABANJO, MD & BEN ALFRED, FNP UMASS FAMILY HEALTH CENTER WORCESTER Management of Hepatitis C in Primary Care BABAFEMI ONABANJO, MD & BEN ALFRED, FNP UMASS FAMILY HEALTH CENTER WORCESTER Objective Epidemiology Screening criteria Appropriate work up Treatment Guidelines

More information

Professor Peter Hayes University of Edinburgh

Professor Peter Hayes University of Edinburgh Professor Peter Hayes University of Edinburgh Acute liver failure BHIVA meeting, April 2018 No disclosures relevant to this presentation ALF DEFINITIONS Trey and Davidson, 1970 Potentially a reversible

More information

Liver function and clinical chemistry of liver

Liver function and clinical chemistry of liver INTRODUCTION Liver function and clinical chemistry of liver The liver plays a major role in carbohydrate, lipid and protein metabolism with the processes of glycolysis, the Krebs cycle,,homeostasis synthesis

More information

Chronic Hepatic Disease

Chronic Hepatic Disease Chronic Hepatic Disease 10 th Leading Cause of Death Liver Functions Energy Metabolism Protein Synthesis Solubilization, Transport, and Storage Protects and Clears drugs, damaged cells Causes of Liver

More information

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals By: Dr. Kevin Dolehide Overview DX Cirrhosis and Prognosis Compensated Decompensated Complications Of Cirrhosis Management Of Complications

More information

4/27/2018. Disclosures LIVER FUNCTION TESTS LIVER FUNCTION TESTS LIVER FUNCTION TESTS APPROACH TO THE PATIENT WITH ABNORMAL LIVER TESTS

4/27/2018. Disclosures LIVER FUNCTION TESTS LIVER FUNCTION TESTS LIVER FUNCTION TESTS APPROACH TO THE PATIENT WITH ABNORMAL LIVER TESTS APPROACH TO THE PATIENT WITH ABNORMAL TESTS Kimberly A. Brown, M.D, FAST, FAASLD, AGAF Chief, Division of Gastroenterology and Hepatology Henry Ford Hospital Henry Ford Health System Detroit, Michigan

More information

Prognosis of untreated Primary Sclerosing Cholangitis (PSC) Erik Christensen Copenhagen, Denmark

Prognosis of untreated Primary Sclerosing Cholangitis (PSC) Erik Christensen Copenhagen, Denmark Prognosis of untreated Primary Sclerosing Cholangitis (PSC) Erik Christensen Copenhagen, Denmark Study of Prognosis of PSC Difficulties: Disease is rare The duration of the course of disease may be very

More information

ASSESSMENT AND MANAGEMENT OF POTENTIAL LIVER TRANSPLANT CANDIDATES

ASSESSMENT AND MANAGEMENT OF POTENTIAL LIVER TRANSPLANT CANDIDATES ASSESSMENT AND MANAGEMENT OF POTENTIAL LIVER TRANSPLANT CANDIDATES James YY Fung MBChB, MD, FRACP, FHKCP, FHKAM Consultant & Hon. Assoc. Professor Liver Transplant Center Department of Surgery, Queen Mary

More information

4/3/2014. Elizabeth Thompson, PharmD April Understand the importance of the liver and basic physiology.

4/3/2014. Elizabeth Thompson, PharmD April Understand the importance of the liver and basic physiology. Liver Disease Elizabeth Thompson, PharmD thompse@sarmc.org April 2014 Objectives Understand the importance of the liver and basic physiology. Review hepatic disorders Recognize liver function scoring systems

More information

Acute Hepatitis: An Approach to Infectious and Other Causes. Mary Anne Cooper MSc, MD, MEd, FRCPC

Acute Hepatitis: An Approach to Infectious and Other Causes. Mary Anne Cooper MSc, MD, MEd, FRCPC : An Approach to Infectious and Other Causes Mary Anne Cooper MSc, MD, MEd, FRCPC Faculty: Dr. Mary Anne Cooper Relationships with commercial interests: Consulting Fees: Lupin Pharmaceuticals, Canada Objectives

More information

Hepatitis C Update on New Treatments

Hepatitis C Update on New Treatments Hepatitis C Update on New Treatments Kevork M. Peltekian, MD, FRCPC 44th Annual Dalhousie Spring Refresher Course - Therapeutics April 5 - April 7, 2018 Halifax Convention Centre Disclosures Conflicts

More information

Steps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV

Steps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV Overview of Liver Disease Associated With HCV Marion G. Peters, MD John V. Carbone, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco San Francisco,

More information

IN THE NAME OF GOD. D r. MANIJE DEZFULI AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL INFECTIOUS DISEASES SPECIALIST

IN THE NAME OF GOD. D r. MANIJE DEZFULI AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL INFECTIOUS DISEASES SPECIALIST IN THE NAME OF GOD AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL D r. MANIJE DEZFULI INFECTIOUS DISEASES SPECIALIST Acute Viral Hepatitis The Anatomy of the Liver Hepatic Physiology Liver: Largest solid organ

More information